H.C. Wainwright Sticks to Its Hold Rating for Ironwood Pharma (IRWD)


In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Ironwood Pharma (IRWD), with a price target of $13. The company’s shares closed on Friday at $10.95.

Selvaraju wrote:

“We utilize a discounted cash flow (DCF)-based approach, which yields a total risk-adjusted net present value (rNPV) of $2.28B, of which roughly $1.93B is based on Ironwood’s ownership stake in linaclotide. The remainder consists of our $355M rNPV for IW-3718, to which we ascribe a 40% probability of approval.”

According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 3.1% and a 33.0% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries Ltd., Biospecifics Technologies Corp, and EyePoint Pharmaceuticals Inc.

Currently, the analyst consensus on Ironwood Pharma is a Hold with an average price target of $13.60, which is a 24.2% upside from current levels. In a report issued on June 18, Cowen & Co. also maintained a Hold rating on the stock with a $12 price target.

See today’s analyst top recommended stocks >>

Based on Ironwood Pharma’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $59.28 million. In comparison, last year the company had a GAAP net loss of $43.14 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Ironwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonist which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts